anoth solid perform
maintain market perform rate stryker corpor follow
releas result compani second quarter result slight beat-
and-rais top bottom line highlight solid organ constant
currenc cc revenu growth y/i three major report segment
one post sale ahead respect consensu estim one
line one total revenu still narrowli exceed street
expect quarterli ep versu prior
year consensu reflect beat compani
rais ep guidanc previou rang midpoint
sit previous
current trade midpoint new ep guidanc compar
consensu orthoped peer mo
pt slightli averag group select large-cap med-tech
peer therefor believ compani share reflect fair valu base
second-quart sale bln y/i cc organ
ahead consensu bln compani medsurg busi continu
standout quarter post highest organ growth major
divis third consecut quarter outpac consensu estim
sole divis medsurg revenu came bln y/i
cc organ street estim expect bln
unit much out-performance result cc y/i jump
instrument subdivis mln vs consensu mln stem
recent sale forc split divid power tool wast manag
syk medsurg segment support organ growth within
endoscopi double-digit growth video busi medic subgroup
orthoped sale bln y/i cc came expect directli
meet consensu estim within busi hip knee revenu
roughli line street expect consensu trauma
come slightli expect mln vs consensu mln
suppli chain issu begin abat hip increas cc
knee tick cc benefit increas mako robot util
drive implant share gain call manag note syk
orthoped robot strategi remain track mako robot instal
 ou ahead place sequenti
sold quarter progress instal base sit north
robot estim nearli locat
thomson reuter jmp secur llc
compani report jmp secur llc
report read conjunct import disclosur inform includ attest regul analyst certif
second quarter total knee procedur exceed y/i aggreg mako
neurotechnolog spine revenu street expect come mln
y/i cc organ compar consensu mln growth driven
continu demand compani neurotech product somewhat off-set slower spine
growth compani continu work integr anticip sale
forc disrupt come
manag updat full-year guidanc rais organ sale growth
previous tweak adjust ep rang
compani comment plan achiev bp oper margin
improv remain track adjust oper margin bp adjust ep
guidanc provid call consensu head
call impact minim third quarter foreign currenc expect neg
affect full-year ep
far segment breakdown orthoped grew y/i organ volum
price hip cc knee cc trauma extrem cc medsurg rose
y/i organ volum price led instrument cc
endoscopi cc medic cc sustain cc final neurotech spine
includ increas y/i organ volum price neurotech
cc spine cc
manag updat sale ep guidanc provid expect ep
figur outlin key metric organ sale growth expect previous
ep tweak previous adjust ep expect
guidancecurrentpriordirectionrevenu number sell day sell day impactadj expect neg impact fx expect impact acquisit dilut stryker corpor
figur contain comparison actual result jmp estim rang revenu
metric along select commentari
 bpslarg joint bpstrauma bpssustain bpsneuro bpstotal blnannual bpsgross bpsdown bp y/i impact favor product effici off-set price fx busi bpsdown bp y/i reflect continu focu oper expens improv cost transform growth ctg program includ key project focus indirect purchas share servic off-set neg impact acquisit plan invest program erp bpsoper bpstax bpslower primarili due benefit relat stock compens expensenet cc sale qtr cc growth cc exclud acquisit volum price cc continu strong demand hemorrhag ischem stroke cmf neuropow instrument product broad base gain cc driven acquisit signific progress made integr continu manag anticip sale forc disrupt primarili impact sale qtr constant currenc organ volum price cc us growth intern cc uptak new trident cup well increas util mako hip procedur double-digit procedur cc robot instal ou continu strong demand mako tka platform mako knee procedur exceed y/i robust order book lead expect strong robot sale cc alpha cc sale qtr cc cc exclud acquisit volum price cc manag continu see benefit sale forc split robust growth across power tool wast manag cc video busi grew doubl digit new camera ramp along novadaq product cc led bed stretcher busi within see strong demand prevalon primafit stryker corpor
one largest compani med-tech year busi develop activ given compani evolv footprint
span well beyond tradit orthoped line three major sale segment today orthopaed hip knee trauma
extrem medsurg instrument endoscopi medic sustain neurotech spine neurosurg neurovascular
devic tradit metal implant orthobiolog mainli spine fusion divis complement nice also offer
signific divers multipl way grow grant compani potenti remain balanc time ideal benefit
abil off-set under-perform line stronger devic sale adjac arena
highli diversifi bring posit neg consequ depend upon underli fundament differ
market volum rebound core orthoped arena may occur would like mute impact growth given
sizabl revenu base price like remain headwind across sector med-tech could worsen new product may perform
well anticip acquisit integr could prove challeng expect signific exposur outsid
ou sale meaning exposur europ asia subject compani headwind tailwind may aris
geographi
research analyst prepar report does/do herebi certifi view present report accord my/our
person view secur issuer discuss report mandat sec regul ac part my/our compens
directli indirectli relat specif view recommend express herein certif made
oblig set forth sec regul ac person entiti may use purpos certif made
base my/our analysi date report public i/w assum oblig updat certif reflect fact
circumst event may subsequ come my/our attent sign david turkali daniel stauder
jmp secur current make market secur stryker corpor inc
jmp secur expect receiv intend seek compens invest bank servic stryker corpor next
market outperform mo jmp secur expect stock price outperform relev market indic next month
market perform mp jmp secur expect stock price perform line relev market indic next month
market under-perform mu jmp secur expect stock price under-perform relev market indic next month
jmp secur research rate invest bank servic juli
servic
co
stock price chart rate price chang
note first annot denot initi coverag year whichev shorter target price list target price n/a
accord finra rule chart reflect price rang chang rate price target end
recent calendar quarter action reflect note annot stock price chart jmp secur
jmp secur llc firm compens research analyst like firm employe base firm profit includ
revenu firm institut sale trade invest bank depart well qualiti servic activ
perform intend benefit firm institut client data prepar jmp secur llc inform
purpos base inform avail public sourc believ reliabl guarante
accuraci complet opinion project express herein reflect judgment date subject chang
without notic data neither intend consid offer sell solicit basi contract
purchas secur financi product jmp secur llc affili jmp group llc harvest capit strategi llc
respect partner director offic associ may long short posit may act market maker may
purchas sell posit secur mention herein jmp secur llc affili may perform perform seek
perform invest bank advisori servic may act manag co-manag public offer secur
compani mention herein reader assum jmp secur llc solicit busi compani cover
report member sale trade depart provid oral and/or written market opinion trade strategi client
reflect person opinion stock subject firm research report research analyst discuss trade
strategi client sometim reflect short-term expect price secur subject research report
trade strategi distinct analyst fundament rate stock base upon analyst view compar
stock coverag relev time period copyright right reserv jmp secur llc jmp secur
llc member finra sipc
director research
director equiti
director sale trade
